News
25m
Investor's Business Daily on MSNSarepta Topples, Again, After Refusing The FDA's Request To Pull ElevidysSarepta stock took another dive Monday after the biotech company refused the FDA's request to voluntarily stop all shipments ...
Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...
Drugmaker Sarepta Therapeutics said late Friday it won't comply with a request from the Food and Drug Administration to halt ...
Most investors don’t see the drugmaker’s executive management as credible, following the failure to disclose a patient death, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results